- Report
- April 2024
- 80 Pages
Russia
From €1386EUR$1,500USD£1,166GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1386EUR$1,500USD£1,166GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1386EUR$1,500USD£1,166GBP
- Report
- February 2024
- 100 Pages
Africa
From €1848EUR$2,000USD£1,555GBP
- Report
- February 2024
- 80 Pages
Saudi Arabia
From €1386EUR$1,500USD£1,166GBP
- Report
- February 2024
- 80 Pages
India
From €1386EUR$1,500USD£1,166GBP
- Report
- February 2024
- 300 Pages
Global
From €2310EUR$2,500USD£1,944GBP
- Report
- January 2024
- 255 Pages
Global
From €2310EUR$2,500USD£1,944GBP
- Report
- January 2024
- 80 Pages
United Kingdom
From €1386EUR$1,500USD£1,166GBP
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 100 Pages
Africa
From €1848EUR$2,000USD£1,555GBP
- Report
- January 2024
- 80 Pages
Brazil
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 80 Pages
China
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 80 Pages
France
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 80 Pages
Germany
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 80 Pages
India
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 80 Pages
Ireland
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 80 Pages
Japan
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 80 Pages
Russia
From €1386EUR$1,500USD£1,166GBP
- Report
- January 2024
- 80 Pages
Saudi Arabia
From €1386EUR$1,500USD£1,166GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more